Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around 6 months after a second dose for most recipients, although a third shot had a strong booster effect, according to a lab study.
Chinese researchers reported the findings from a study of blood samples from healthy adults aged between 18-59 in a paper published last 25 July, which has not been peer reviewed.